RE:Object permanence:Proph, I'm sure you saw my last post before it was removed so enough said about the endless rationalizations for the endless failures of execution at Ceapro. you have been spewing since forever. As far as your above post the question isnt as you propose that sales of Aveeno have slowed it is assuming they are progressing as normal who is supplying the Avanathrimedes? Is there another player?
Gilles as we know is a shameless liar and would never admit that the collapse in revenue could be due to competition and that these sales may be lost.
Q3 is 2/3 over and any responsible CEO would. as part of Q2's numbers inform his shareholders that Q3 sales are tracking on a more normal pace. Not effing Gilles he is content to let everyone hang in limbo.
I will say again at the risk of redundancy. You were not missed.